Cargando…
Diffusion of an innovation: growth in video capsule endoscopy in the U.S. Medicare population from 2003 to 2019
BACKGROUND: Video capsule endoscopy (VCE), approved by the U.S. Food and Drug Administration (FDA) in 2001, represented a disruptive technology that transformed evaluation of the small intestine. Adoption of this technology over time and current use within the U.S. clinical population has not been w...
Autores principales: | Read, Andrew J., Rice, Michael D., Baker, Jason R., Waljee, Akbar K., Saini, Sameer D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969398/ https://www.ncbi.nlm.nih.gov/pubmed/35361221 http://dx.doi.org/10.1186/s12913-022-07780-2 |
Ejemplares similares
-
Medicare modernization and diffusion of endoscopy in FFS medicare
por: Mobley, Lee R., et al.
Publicado: (2017) -
The epidemiology and etiology of adhesive capsulitis in the U.S. Medicare population
por: Sarasua, Sara M., et al.
Publicado: (2021) -
Contraindications for video capsule endoscopy
por: Bandorski, Dirk, et al.
Publicado: (2016) -
Video Capsule Endoscopy in Gastroenterology
por: Ahmed, Monjur
Publicado: (2022) -
Kvasir-Capsule, a video capsule endoscopy dataset
por: Smedsrud, Pia H., et al.
Publicado: (2021)